2937.12.00.00/Human Insulin (rDNA)/China

Human Insulin (rDNA) from China

Recombinant human insulin produced via DNA technology, a polypeptide hormone used primarily for treating diabetes mellitus. Classified under HTS 2937.12.00.00 as a synthetic reproduction of insulin, the exact structural analogue of natural human insulin. Meets chapter 29 requirements for chemically defined organic compounds used as hormones.

Duty Rate — China → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Requires FDA approval and biologics license; provide certificates of analysis confirming rDNA origin and purity

• Maintain strict cold chain (2-8°C) documentation throughout transport to preserve bioactivity

• Declare as 'insulin, synthetic' to avoid misclassification with pharmaceutical preparations in Chapter 30

Human Insulin (rDNA) from China — Import Duty Rate | HTS 2937.12.00.00